Chargement en cours...
Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis
Patients with yersinia triggered reactive arthritis were double blind randomly allocated to receive treatment with ciprofloxacin 500 mg twice daily orally or placebo during three months. The diagnosis was made by serology (specific IgA and IgG antibodies to yersinia outer membrane proteins (yops)),...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2000
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1753019/ https://ncbi.nlm.nih.gov/pubmed/11053072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.59.11.914 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|